In partnership with Ipsos, ixlayer surveyed over 400 patients with chronic conditions to explore their motivations, barriers, and expectations around digital health. The findings offer a clear blueprint for biopharma companies looking to deliver more seamless, supportive, and scalable direct-to-patient (DTP) solutions.
In partnership with Ipsos, ixlayer surveyed patients with chronic conditions to explore their motivations, barriers, and expectations around digital health. The findings offer a clear blueprint for biopharma companies looking to deliver more seamless, supportive, and scalable direct-to-patient (DTP) solutions. This report sheds light on: